Patents by Inventor Richard Labotka

Richard Labotka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY FOR CANCER TREATMENT
    Publication number: 20230201227
    Abstract: The present disclosure relates to methods for treating cancer, or preventing cancer recurrence or progression, comprising administering a patient an anti-CD38 antibody and a proteasome inhibitor.
    Type: Application
    Filed: March 16, 2023
    Publication date: June 29, 2023
    Inventors: Richard Labotka, Andrew Fergus
  • COMBINATION THERAPY FOR CANCER TREATMENT
    Publication number: 20220184103
    Abstract: The present disclosure relates to methods for treating cancer, or preventing cancer recurrence or progression, comprising administering a patient an anti-CD38 antibody and a proteasome inhibitor.
    Type: Application
    Filed: February 25, 2022
    Publication date: June 16, 2022
    Inventors: Richard Labotka, Andrew Fergus
  • Methods for cancer therapy
    Patent number: 11241448
    Abstract: The present disclosure relates to methods or dosing regimens comprising a proteasome inhibitor of formula (I), or a pharmaceutically acceptable salt thereof, for treating cancer, or preventing cancer recurrence or progression; wherein ring A, Z1 and Z2 are as defined herein.
    Type: Grant
    Filed: March 1, 2021
    Date of Patent: February 8, 2022
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Ai-Min Hui, Richard Labotka, Neeraj Gupta, Karthik Venkatakrishnan, Guohui Liu
  • COMBINATION THERAPY FOR CANCER TREATMENT
    Publication number: 20210369748
    Abstract: The present disclosure relates to methods for treating cancer, or preventing cancer recurrence or progression, comprising administering a patient an anti-CD38 antibody and a proteasome inhibitor.
    Type: Application
    Filed: August 2, 2021
    Publication date: December 2, 2021
    Inventors: Richard Labotka, Andrew Fergus
  • METHODS FOR CANCER THERAPY
    Publication number: 20210177871
    Abstract: The present disclosure relates to methods or dosing regimens comprising a proteasome inhibitor of formula (I), or a pharmaceutically acceptable salt thereof, for treating cancer, or preventing cancer recurrence or progression; wherein ring A, Z1 and Z2 are as defined herein.
    Type: Application
    Filed: March 1, 2021
    Publication date: June 17, 2021
    Inventors: Ai-Min Hui, Richard Labotka, Neeraj Gupta, Karthik Venkatakrishnan, Guohui Liu
  • COMBINATION THERAPY FOR CANCER TREATMENT
    Publication number: 20210137955
    Abstract: The present disclosure relates to methods for treating cancer, or preventing cancer recurrence or progression, comprising administering a patient an anti-CD38 antibody and a proteasome inhibitor.
    Type: Application
    Filed: January 21, 2021
    Publication date: May 13, 2021
    Inventors: Richard Labotka, Andrew Fergus
  • Methods for Cancer Therapy
    Publication number: 20200171061
    Abstract: The present disclosure relates to methods or dosing regimens comprising a proteasome inhibitor of formula (I), or a pharmaceutically acceptable salt thereof, for treating cancer, or preventing cancer recurrence or progression; wherein ring A, Z1 and Z2 are as defined herein.
    Type: Application
    Filed: February 4, 2020
    Publication date: June 4, 2020
    Inventors: Ai-Min Hui, Richard Labotka, Neeraj Gupta, Karthik Venkatakrishnan, Guohui Liu
  • METHODS FOR CANCER THERAPY
    Publication number: 20190343851
    Abstract: The present disclosure relates to methods or dosing regimens comprising a proteasome inhibitor of formula (I), or a pharmaceutically acceptable salt thereof, for treating cancer, or preventing cancer recurrence or progression; wherein ring A, Z1 and Z2 are as defined herein.
    Type: Application
    Filed: July 22, 2019
    Publication date: November 14, 2019
    Inventors: AI-MIN HUI, Richard Labotka, Neeraj Gupta, Karthik Venkatakrishnan, Guohui Liu
  • METHODS FOR CANCER THERAPY
    Publication number: 20190125773
    Abstract: The present disclosure relates to methods or dosing regimens comprising a proteasome inhibitor of formula (I), or a pharmaceutically acceptable salt thereof, for treating cancer, or preventing cancer recurrence or progression; wherein ring A, Z1 and Z2 are as defined herein.
    Type: Application
    Filed: December 21, 2018
    Publication date: May 2, 2019
    Inventors: AI-MIN HUI, Richard Labotka, Neeraj Gupta, Karthik Venkatakrishnan, Guohui Liu
  • COMBINATION THERAPY FOR CANCER TREATMENT
    Publication number: 20180235986
    Abstract: The present disclosure relates to methods for treating cancer, or preventing cancer recurrence or progression, comprising administering a patient an anti-CD38 antibody and a proteasome inhibitor.
    Type: Application
    Filed: February 16, 2016
    Publication date: August 23, 2018
    Inventors: Richard Labotka, Andrew Fergus
  • METHOD FOR CANCER THERAPY
    Publication number: 20150335668
    Abstract: The present disclosure relates to methods or dosing regimens comprising a proteasome inhibitor of formula (I), or a pharmaceutically acceptable salt thereof, for treating cancer, or preventing cancer recurrence or progression; wherein ring A, Z1 and Z2 are as defined herein.
    Type: Application
    Filed: May 19, 2015
    Publication date: November 26, 2015
    Inventors: AI-MIN HUI, Richard Labotka, Neeraj Gupta, Karthik Venkatakrishnan, Guohui Lui